NEFROLOGÍA

2011

Artículos

 

Fiorante S, Fernández Ruiz M, López Medrano F, Lizasoaín M, Lalueza A, Morales JM, et al. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. Nephrol Dial Transplant. 2011;26(3):1065-73.

 

García Donaire JA, Ruilope LM. Cardiovascular and renal links along the cardiorenal continuum. Int J Nephrol. 2011;2011:975782.

 

García Donaire JA, Segura J, Cerezo C, Ruilope LM. A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients. Blood Press. 2011;20(6):322-34.

 

García Reyne A, López Medrano F, Morales JM, García Esteban C, Martín I, Eraña I, et al. Cutaneous infection by Phomopsis longicolla in a renal transplant recipient from Guinea: first report of human infection by this fungus. Transpl Infect Dis. 2011;13(2):204-7.

 

Rodríguez Aranda A, Alcázar JM, Sanz F, García Martín F, Otero JR, Aguado JM, et al. Endoluminal colonization as a risk factor for coagulase-negative staphylococcal catheter-related bloodstream infections in haemodialysis patients. Nephrol Dial Transplant. 2011;26(3):948-55.

 

Ruilope LM. Current challenges in the clinical management of hypertension. Nat Rev Cardiol. 2011;9(5):267-75.

 

Ruilope LM. Hypertension in 2010: Blood pressure and the kidney. Nat Rev Nephrol. 2011;7(2):73-4.

 

Ruilope LM. Telmisartan for the management of patients at high cardiovascular risk. Curr Med Res Opin. 2011;27(8):1673-82.

 

Ruilope LM, Bakris GL. Renal function and target organ damage in hypertension. Eur Heart J. 2011;32(13):1599-604.

 

Ruilope LM, Schaefer A. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study. Contemp Clin Trials. 2011;32(5):710-6.

 

Ruilope LM, Segura J, Zamorano JL. New clinical concepts after the ONTARGET trial. Expert Rev Cardiovasc Ther. 2011;9(6):685-9.

 

Ruilope LM, Solini A. RAS blockade for every diabetic patient: pro and con. Diabetes Care. 2011;34(Suppl 2):S320-4.

 

Segura J, Cerezo C, García Donaire JA, Schmieder RE, Praga M, De la Sierra A, et al. Validation of a therapeutic scheme for the treatment of resistant hypertension. J Am Soc Hypertens. 2011;5(6):498-504.

 

Segura J, Ruilope LM. Clinical utility of fixed-combination telmisartan-amlodipine in the treatment of hypertension. Integr Blood Press Control. 2011;4:27-34.

 

Segura J, Ruilope LM. Dual-acting angiotensin receptor-neprilysin inhibition. Curr Hypertens Rep. 2011;13(1):74-8.

 

Segura J, Ruilope LM. Hypertension in moderate-to-severe nondiabetic CKD patients. Adv Chronic Kidney Dis. 2011;18(1):23-7

.

2012

Artículos

Banegas JR, Graciani A, De la Cruz Troca JJ, León Muñoz LM, Guallar Castillón P, Coca A, et al. Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study. Hypertension. 2012;60(4):898-905.

Cerezo C, Ruilope LM, Segura J, García Donaire JA, De la Cruz JJ, Banegas JR, et al. Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression. J Hypertens. 2012;30(1):204-9.

Fernández Ruiz M, López Medrano F, Varela Peña P, Lora Pablos D, García Reyne A, González E, et al. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection. Am J Transplant. 2012;12(10):2763-73.

García Donaire JA, Dalfó Baqué A, Sanclemente Ansó C, Urdiales Castillo D, Martínez Debén F, Ortega López N, et al. [Medida de la presión arterial en consulta y automatizada (BPTru®) para evaluar el efecto de bata blanca. Med Clin (Barc). 2012;138(14):597-601.

Gutiérrez E, Egido J, Rubio Navarro A, Buendía I, Blanco Colio LM, Toldos O, et al. Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract. 2012;121(1-2):c42-53.

Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol. 2012;23(10):1753-60.

Huerta A, Bomback AS, Liakopoulos V, Palanisamy A, Stokes MB, D’Agati VD, et al. Renal-limited “lupus-like” nephritis. Nephrol Dial Transplant. 2012;27(6):2337-42

Labiano Fontcuberta A, Benito León J, Bermejo Pareja F. Alteraciones neuropsiquiátricas en el temblor esencial. Med Clin (Barc). 2012;138(4):171-6.

López Medrano F, Carratalà J, Cruzado JM, Gutiérrez MJ, Aguado JM. Fever in a kidney transplant recipient: no facts and many interactions. Rev Clin Esp. 2012;212(4):193-7.

Morales E, Morales R, Gutiérrez E, Rojas Rivera J, Praga M. Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient. Clin Kidney J. 2012;5(6):608-9.

Morales E, Praga M. The effect of weight loss in obesity and chronic kidney disease. Curr Hypertens Rep. 2012;14(2):170-6.

Morales JM, Bloom R, Roth D. Kidney transplantation in the patient with hepatitis C virus infection. Contrib Nephrol. 2012;176:77-86.

Morales JM, Kamar N, Rostaing L. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy. Contrib Nephrol. 2012;176:10-23.

Morales JM, Marcén R, Del Castillo D, Andrés A, González Molina M, Oppenheimer F, et al. Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study. Nephrol Dial Transplant. 2012;27(Suppl 4):iv39-46.

Morales JM, Varo E, Lázaro P. Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain. Clin Transplant. 2012;26(2):369-76.

Polanco N, Gutiérrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D, et al. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol Dial Transplant. 2012;27(1):231-4.

Praga M, Rojas Rivera J. Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy. Nat Rev Nephrol. 2012;8(9):496-8.

Praga M, Gutiérrez Solís E, Morales E. Hepatitis C-induced renal disease in patients with AIDS: an emergent problem. Contrib Nephrol. 2012;176:24-34.

Ruilope LM, Schmieder R. Current status of renal denervation in resistant hypertension. J Am Soc Hypertens. 2012;6(6):414-6.

Ruilope LM, Schumacher H. Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension. Expert Opin Pharmacother. 2012;13(16):2417-25.

Segura J, Ruilope LM. Are there new threshold and goals in the treatment of arterial hypertension? Eur J Clin Invest. 2012;42(8):914-20.

Serrano A, García F, Serrano M, Ramírez E, Alfaro FJ, Lora D, et al. IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality. Kidney Int. 2012;81(12):1239-44.

Serrano M, Meneu JC, Medina E, Alfaro FJ, Martínez Flores JA, Mora S, et al. Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. Transplant Proc. 2012;44(9):2622-4.

Sevillano Prieto AM, Hernández Martínez E, Caro Espada J, Molina Gómez M, Gutiérrez Martínez E, Morales Ruiz E, et al. Cholesterol atheroembolism and combined treatment with steroids and iloprost. Nefrologia. 2012;32(6):824-8.

.

2013

Artículos

Armario P, Oliveras A, Hernández del Rey R, Suárez C, Martell N, Ruilope LM, et al. Increased pulse pressure is associated with left atrial enlargement in resistant hypertensive patients. Blood Pressure. 2013;22(1):39-44 [PubMed]

Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe UC et al. Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. EuroIntervention. 2013 Aug 22;9(4):484-92. [PubMed]

Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa M, Grinyo JM, et al. Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso. Nefrologia. 2013;33(1):27-45. [PubMed]

Campistol JM, Carreño A, Morales JM, Pallardo L, Franco A, Navarro D, et al. Once-monthly pegylated epoetin beta versus darbepoetin alfa every two weeks in renal transplant recipients: A randomized trial. Transplantation. 2013;95(2):E6-E10 [PubMed]

Caro J, Morales E, Gutiérrez E, Ruilope LM, Praga M. Malignant hypertension in patients treated with vascular endothelial growth factor inhibitors. J Clin Hypertens (Greenwich). 2013;15(3):215-6 [PubMed]

Cerezo C, Segura J, Praga M, Ruilope LM. Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension. Curr Hypertens Rep. 2013;15(3):196-203 [PubMed]

Claverie Martín F, García Nieto V, Loris C, Ariceta G, Nadal I, Espinosa L, et al. Claudin-19 mutations and clinical phenotype in spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One. 2013;8(1) [PubMed]

ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice
guidelines for the management of arterial hypertension of the European Society of
Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task
Force for the Management of Arterial Hypertension. J Hypertens. 2013
Oct;31(10):1925-38.[PubMed]

Fernández Juárez G, Luño J, Barrio V, García de Vinuesa S, Praga M, Goicoechea M, et al. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Clin J Am Soc Nephrol. 2013;8(11):1870-6 [PubMed]

Fernández Juárez G, Luño J, Barrio V, Garcia de Vinuesa S, Praga M, Goicoechea M, et al. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: A randomized trial. Am J Kidney Dis. 2013;61(2):211-8 [PubMed]

Fernández Ruiz M, López Medrano F, Andrés A, Morales JM, Lumbreras C, San Juan R, et al. Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients. Transpl Infect Dis. 2013;15(6):600-11 [PubMed]

Fernández Ruiz M, Andrés A, López Medrano F, González E, Lumbreras C, San-Juan R, et al. Infection risk in kidney transplantation from uncontrolled donation after circulatory death donors. Transplant Proc. 2013;45(4):1335-8 [PubMed]

Fernández Ruiz M, López Medrano F, Varela Peña P, Morales JM, García Reyne A, San Juan R, et al. Hypocomplementemia in kidney transplant recipients: impact on the risk of infectious complications. Am J Transplant. 2013;13(3):685-94 [PubMed]

Fontenla A, García Donaire JA, Hernández F, Segura J, Salgado R, Cerezo C, et al. Management of resistant hypertension in a multidisciplinary unit of renal denervation: protocol and results. Rev Esp Cardiol. 2013;66(5):364-70. [PubMed]

Fontenla A, García Donaire JA, Ruilope LM, Arribas F. Comentario al manejo de la hipertensión resistente en una unidad multidisciplinaria de denervación renal: protocolo y resultados. Respuesta. Rev Esp Cardiol. 2013;66(10):830-1 [PubMed]

Gómez AM, Ruiz Hurtado G, Benitah JP, Domínguez Rodríguez A. Ca(2+) fluxes involvement in gene expression during cardiac hypertrophy. Curr Vasc Pharmacol. 2013;11(4):497-506 [PubMed]

González E, Rojas Rivera J, Polanco N, Morales E, Morales JM, Egido J, et al. Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients. Transplantation. 2013;95(7):E49-52 [PubMed]

Gorostidi M, Sarafidis PA, De la Sierra A, Segura J, De la Cruz JJ, Banegas JR, et al. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain. Am J Kidney Dis. 2013;62(2):285-94 [PubMed]

Jiménez C, González E, Marqués M, Galeano C, Andrés A, Calvo N, et al. Impacto de darbepoetina alfa en el manejo de la anemia precoz postrasplante renal: estudio retrospectivo exploratorio. Nefrologia. 2013;33(1):107-15 [PubMed]

López-Pintor RM, Hernández G, de Arriba L, de Andrés A. Oral candidiasis in patients with renal transplants. Med Oral Patol Oral Cir Bucal. 2013 May 1;18(3):e381-7. [PubMed]

Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-357 [PubMed]

Martínez MA, Bárcena C, Ramchandani B, Rodríguez Gil Y, Morales JM. Membranous glomerulopathy in renal allograft: an ultrastructural study of 17 cases. Ultrastruct Pathol. 2013;37(6):379-85 [PubMed]

Martínez Flores JA, Serrano M, Alfaro J, Mora S, Paz Artal E, Morales JM, et al. Heterogeneity between diagnostic tests for IgA anti-beta2 glycoprotein I: Explaining the controversy in studies of association with vascular pathology. Anal Chem. 2013;85(24):12093-8 [PubMed]

Mazuecos A, Fernández A, Zárraga S, Andrés A, Rodríguez Benot A, Jiménez C, et al. High incidence of delayed graft function in HIV-infected kidney transplant recipients. Transpl Int. 2013;26(9):893-902 [PubMed]

Mentz RJ, Bakris GL, Waeber B, McMurray JJV, Gheorghiade M, Ruilope LM, et al. The past, present and future of renin-angiotensin aldosterone system inhibition. Int J Cardiol. 2013;167(5):1677-87 [PubMed]

Miranda Utrera N, Medina Polo J, Pamplona M, De la Rosa F, Rodríguez A, Duarte JM, et al. Donation after cardiac death: results of the SUMMA 112 – Hospital 12 de Octubre Program. Clin Transplant. 2013;27(2):283-8 [PubMed]

Molina M, Sánchez J, Sevillano ÁM, Bengoa I, Gutiérrez E, Martínez MA, et al. Dos glomerulonefritis en un mismo paciente con infección por virus de la hepatitis C. Nefrologia. 2013;33(4):593-600 [PubMed]

Morales E, Enrique M, Caro J, Jara C. Reply to vascular endothelial growth factor: a novel potential therapeutic target for hypertension. J Clin Hypertens (Greenwich). 2013;15(7):515 [PubMed]

Morales E, Millet VG, Rojas Rivera J, Huerta A, Gutiérrez E, Gutiérrez Solís E, et al. Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. Nephrol Dial Transplant. 2013;28(2):405-12 [PubMed]

Muñiz-Pacios L, Morales-Ruiz E, Aguilar F, García-Martín F. Insuficiencia renal crónica secundaria a amiloidosis sistémica asociada a tumor del estroma gastrointestinal. Nefrologia. 2013;33(4):620-2. [PubMed]

O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731-68 [PubMed]

Ojo AO, Morales JM, González Molina M, Steffick DE, Luan FL, Merion RM, et al. Comparison of the long-term outcomes of kidney transplantation: USA versus Spain. Nephrol Dial Transplant. 2013;28(1):213-20 [PubMed]

Oliveras A, García Ortiz L, Segura J, Banegas JR, Martell Claros N, Vigil L, et al. Association between urinary albumin excretion and both central and peripheral blood pressure in subjects with insulin resistance. J Hypertens. 2013;31(1):103-8 [PubMed]

Palomares I, Ramos R, Martín Malo A, Merello JI, Praga M, Luño J, et al. Compliance with mineral metabolism targets in haemodialysis patients: Moving backwards? Blood Purif. 2013;36(2):122-31 [PubMed]

Pascual J, Jiménez C, Franco A, Gil M, Obrador Mulet AR, Gentil MA, et al. Early-onset anemia after kidney transplantation is an independent factor for graft loss: a multicenter, observational cohort study. Transplantation. 2013;96(8):717-25. [PubMed]

Pascual J, Cruzado JM, Alonso A, Diekman F, Gallego RJ, Gutiérrez Dalmau A, et al. Kidney Transplantation Group of the Spanish Society of Nephrology. Nefrologia. 2013;33(2):160-3 [PubMed]

Portolés J, Luis Gorriz J, Rubio E, De Álvaro F, García F, Álvarez Chivas V, et al. The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease. BMC Nephrol. 2013;14:2 [PubMed]

Praga M, Merello JI, Palomares I, Bayh I, Marcelli D, Aljama P, et al. Type of vascular access and survival among very elderly hemodialysis patients. Nephron Clin Pract. 2013;124(1-2):47-53 [PubMed]

Rabasco Ruiz C, Huerta Arroyo A, Caro Espada J, Gutiérrez Martínez E, Praga Terente M. Glomerulopatías C3. Una nueva perspectiva en enfermedades glomerulares. Nefrologia. 2013;33(2):164-70 [PubMed]

Rivera F, Illescas ML, López-Rubio E, Fulladosa J, Poveda R, Baltar J et al. Mycophenolate as maintenance therapy for lupus nephritis with impaired renal function. Am J Nephrol. 2013;37(6):509-17. [PubMed]

Ruilope LM. Can the effectiveness of hypertension management be improved? Expert Rev Cardiovasc Ther. 2013;11(6):689-95 [PubMed]

Ruilope LM. Chronic kidney disease: Blood pressure control in CKD-still a matter of debate. Nat Rev Nephrol. 2013;9(10):572-3 [PubMed]

Ruilope LM. Long-term adherence to therapy: the clue to prevent hypertension consequences. Eur Heart J. 2013;34(38):2931-2 [PubMed]

Ruilope LM, Arribas F. Hipertensión arterial resistente: de la prevención a la denervación renal. Med Clin (Barc). 2013 Jul 7;141(1):27-8. doi: 10.1016/j.medcli.2012.11.023. [PubMed]

Ruilope LM, Pontremoli R. Serum uric acid and cardio-renal diseases. Curr Med Res Opin. 2013;29:25-31 [PubMed]

Ruilope L, Schaefer A. The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: A randomized, double-blind trial in patients with hypertension. Adv Ther. 2013;30(12):1086-99 [PubMed]

Ruiz Hurtado G, Morel E, Domínguez Rodríguez A, Llach A, Lezoualc’h F, Benitah JP, et al. Epac in cardiac calcium signaling. J Mol Cell Cardiol. 2013;58:162-71 [PubMed]

San Juan R, De Dios B, García Reyne A, Fernández Ruiz M, Lumbreras C, López Medrano F, et al. Limited impact of cytomegalovirus infection in the long-term outcome of renal and liver transplant. J Clin Virol. 2013;56(4):316-22 [PubMed]

San Juan R, De Dios B, Navarro D, García Reyne A, Lumbreras C, Bravo D, et al. Epstein-Barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients. Transplantation. 2013;95(5):688-93 [PubMed]

Sánchez Zapardiel E, Castro Panete MJ, Castillo Rama M, Morales P, Lora Pablos D, Valero Hervás D, et al. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period. Transplantation. 2013;96(1):70-8 [PubMed]

Sarafidis PA, Ruilope LM. Blood pressure targets for patients with chronic kidney disease. Blood Pressure. 2013;22(6):395-6 [PubMed]

Sarafidis PA, Ruilope LM. Renin-Angiotensin-Aldosterone system blockade in hypertensive patients with chronic kidney disease. Blood Pressure. 2013;22(6):397-8 [PubMed]

Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM et al. International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol. 2013
Dec 3;62(22):2031-45. [PubMed]

Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, et al. Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention. 2013;9 Suppl R:R58-66 [PubMed]

Segura J, De la Sierra A, Fernández S, Ruilope LM, en representación de los investigadores del estudio IDENTCARE. Influencia de la diabetes sobre la prevalencia de lesión de órganos diana y  enfermedad cardiovascular en los pacientes hipertensos de alto riesgo. Med Clin (Barc). 2013;141(7):287-91. [PubMed]

Segura J, Ruilope LM. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide. Vasc Health Risk Manag. 2013;9:521-8 [PubMed]

Segura J, Ruilope LM. Contribución del riñón en la homeostasis de la glucosa. Med Clin (Barc). 2013;141 Suppl 2:26-30 [PubMed]

Segura J, Salazar J, Ruilope LM. Dual neurohormonal intervention in CV disease: angiotensin receptor and Neprilysin inhibition. Expert Opin Investig Drugs. 2013;22(7):915-25 [PubMed]

Segura de la Morena J, Ruilope Urioste LM. ¿Qué cifras de presión arterial tienen más influencia en la aparición de lesión orgánica en los pacientes con hipertensión resistente? Med Clin (Barc). 2013;140(1):20-1 [PubMed]

Solini A, Ruilope LM. How can resistant hypertension be identified and prevented? Nat Rev Cardiol. 2013;10(5):293-6 [PubMed]

Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JGF, et al. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail. 2013;15(10):1082-94

Congresos

Aguado J, Fernández Ruiz M, Arias M, Campistol J. Epidemiology and prevention approaches for cytomegalovirus (CMV) disease in CMV-seropositive kidney transplant (KT) recipients: Results from a multicenter, prospective, cohort study (OPERA Study). Am J Transplant. 2013;13:210 [American Transplant Congress (13. Seattle, WA. 2013)]

Andrés A, Molina M, González E, Sevillano A, Gutiérrez E, Polanco N, et al. Effectiveness in kidney donation of uncontrolled donation after Cardiac Death (UDCD) Program with out-of-hospital deceased people. Am J Transplant. 2013;13:195-6 [American Transplant Congress (13. Seattle, WA. 2013)]

Andrés A, González E, Polanco N, García Puente L, Morales J, Molina M, et al. Extended-release tacrolimus therapy is effective and safe in de novo kidney transplant recipients from living and expanded, standard, or after cardiac death deceased Donors. Am J Transplant. 2013;13:428 [American Transplant Congress (13. Seattle, WA. 2013)]

Apaza J, González E, Gutiérrez E, Andrés A, Polanco N, Bengoa I, et al. Impact of the determination of HLA antibodies in kidney transplant over ten years of monitoring. Am J Transplant. 2013;13:332 [American Transplant Congress (13. Seattle, WA. 2013)]

Budde K, Morales J, Blancho G, Muehlbacher F, Lehner F, Rice K, et al. Impact of donor age on three-year outcomes in recipients of extended criteria kidneys treated with belatacept vs cyclosporine in BENEFIT-EXT trial. Am J Transplant. 2013;13:182-3 [American Transplant Congress (13. Seattle, WA. 2013)]

Fernández Ruiz M, López Medrano F, Allende L, Varela P, San Juan R, Lumbreras C, et al. A simple post-transplant immunological score accurately predicts the risk of infection in kidney transplant (KT) recipients. Am J Transplant. 2013;13:185-6 [American Transplant Congress (13. Seattle, WA. 2013)]

González E, Polanco N, Molina M, Gutiérrez E, García Puente L, Sevillano A, et al. Effectiveness in kidney donation of uncontrolled donation after Cardiac Death (UDCD) Program with out-of-hospital deceased people. Nephrol Dial Transplant. 2013;28:280-1 [European Renal Association – European Dialysis and Transplant Association Congress (50. Istanbul, Turkey. 2013)]

Lindley E, Cruz Casal M, Rogers S, Pancirova J, Kernc J, Copley JB, et al. Dietary trends and management of hyperphosphataemia among dialysis patients. Nephrol Dial Transplant. 2013;28:464 [European Renal Association – European Dialysis and Transplant Association Congress (50. Istanbul, Turkey. 2013)]

Molina M, González E, Gutiérrez E, Sevillano A, Polanco N, Morales E, et al. Risk factors in venous thrombosis of renal grafts from deceased non heart-beating donors. Nephrol Dial Transplant. 2013;28:499 [European Renal Association – European Dialysis and Transplant Association Congress (50. Istanbul, Turkey. 2013)]

Molina M, González E, Polanco N, García Puente L, Sevillano A, Gutiérrez E, et al. Risk factors in venous thrombosis of renal grafts from deceased non heart-beating donors. Am J Transplant. 2013;13:128 [American Transplant Congress (13. Seattle, WA. 2013)]

Muñoz Robles J, Samaniego L, Marcén R, Andrés A, Seron D, Morales J. The combination of renal dysfunction plus proteinuria at one year Is a strong predictor of early graft Loss after Renal Transplantation. A National Spanish Study. Am J Transplant. 2013;13:424 [American Transplant Congress (13. Seattle, WA. 2013)]

Origüen J, López Medrano F, Pérez Jacoiste M, García Reyne A, Fernández Ruiz M, Carrasco N, et al. Prospective comparative study of a strategy of systematic search and treatment versus no treatment of asymptomatic bacteriuria (AB) in kidney transplant (KT) recipients: preliminary results. Am J Transplant. 2013;13:342 [American Transplant Congress (13. Seattle, WA. 2013)]

Rojas Rivera J, González E, Polanco N, Morales E, Andrés A, Morales JM, et al. Effects of oral paricalcitol on secondary hyperparathyroidism and residual proteinuria of kidney transplant patients. Nephrol Dial Transplant. 2013;28:281 [European Renal Association – European Dialysis and Transplant Association Congress (50. Istanbul, Turkey. 2013)]

Sánchez Zapardiel E, Castro Panete M, Castillo Rama M, Morales P, Lora Pablos D, Valero Hervás D, et al. Preformed snti-MICA antibodies negatively impact renal allograft evolution in early post-transplantation period. Am J Transplant. 2013;13:334 [American Transplant Congress (13. Seattle, WA. 2013)]

Sevillano AM, Molina M, Gutiérrez E, Morales E, Huerta A, Hernández E, et al. Acute Kidney Injury (AKI) induced by macroscopic hematuria in acute glomerulonephritis associated to staphylococcus. Nephrol Dial Transplant. 2013;28:397 [European Renal Association – European Dialysis and Transplant Association Congress (50. Istanbul, Turkey. 2013)]

Sevillano AM, Molina M, Gutiérrez E, Morales E, González E, Hernández E, et al. Renal cysts in thin basement membrane disease (tbmd) with proteinuria/renal function impairment. Nephrol Dial Transplant. 2013;28:396-7 [European Renal Association – European Dialysis and Transplant Association Congress (50. Istanbul, Turkey. 2013)]

.

2014

Artículos

Bakris G, Sarafidis P, Agarwal R, Ruilope L. Review of blood pressure control rates and outcomes. J Am Soc Hypertens. 2014;8(2):127-41 [PubMed]
JCR Factor de Impacto: 2,606
JCR Cuartil: Q3
JCR Decil: D6
JCR Posición: 31/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Banegas JR, Ruilope LM, De la Sierra A, De la Cruz JJ, Gorostidi M, Segura J, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014;35(46):3304-12 [PubMed]
JCR Factor de Impacto: 15,203
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 2/123
JCR Categoría: CARDIAC & CARDIOVASCULAR SYSTEMS

Brañas P, Morales E, Ríos F, Sanz F, Gutiérrez E, Quintanilla N, et al. Usefulness of endoluminal catheter colonization surveillance cultures to reduce catheter-related bloodstream infections in hemodialysis. Am J Infect Control. 2014;42(11):1182-7 [PubMed]
JCR Factor de Impacto: 2,206
JCR Cuartil: Q2
JCR Decil: D4
JCR Posición: 56/165
JCR Categoría: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Calvo Bonacho E, Ruilope LM, Sánchez Chaparro MA, Cerezo C, Catalina Romero C, Martínez Muñoz P, et al. Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study. Eur Heart J. 2014;35(5):299-306 [PubMed]
JCR Factor de Impacto: 15,203
JCR Cuartil: Q2
JCR Decil: D4
JCR Posición: 56/165
JCR Categoría: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Calvo Pulido J, Jiménez Romero C, Morales Ruíz E, Cambra Molero F, Manrique Municio A, García Sesma A, et al. Renal failure associated with intestinal transplantation: our experience in Spain. Transplant Proc. 2014;46(6):2140-2 [PubMed]
JCR Factor de Impacto: – –
JCR Cuartil: – –
JCR Decil: – –
JCR Posición: – –
JCR Categoría: – –

Castillo I, Martínez Ara J, Olea T, Bartolomé J, Madero R, Hernández E, et al. High prevalence of occult hepatitis C virus infection in patients with primary and secondary glomerular nephropathies. Kidney Int. 2014;86(3):619-24 [PubMed]
JCR Factor de Impacto: 8,563
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 4/78
JCR Categoría: UROLOGY & NEPHROLOGY

Cavero Escribano T, Morales Ruiz E, Manzano Pena MT, Muñoz Gómez R, Hernández Martínez E, Gutiérrez Martínez E, et al. Acute rejection of non-functional renal grafts in dialysis patients after starting treatment with interferon and ribavirin. Nefrologia. 2014;34(2):230-4 [PubMed]
JCR Factor de Impacto: 1,223
JCR Cuartil: Q3
JCR Decil: D8
JCR Posición: 57/78
JCR Categoría: UROLOGY & NEPHROLOGY

De La Rosa F, Pamplona M, García González L, Sopeña R, Medina J, Jiménez E, et al. Transplantation rénale à partir de donneurs décédés d’arrêt cardiaque : facteurs de risque pour la thrombose veineuse. Prog Urol. 2014;24(13):854-5 [PubMed]
JCR Factor de Impacto: 0,658
JCR Cuartil: Q4
JCR Decil: D9
JCR Posición: 70/78
JCR Categoría: UROLOGY & NEPHROLOGY

De la Sierra A, Calhoun DA, Vinyoles E, Banegas JR, De la Cruz JJ, Gorostidi M, et al. Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance. J Hum Hypertens. 2014;28(7):416-20 [PubMed]
JCR Factor de Impacto: 2,700
JCR Cuartil: Q2
JCR Decil: D5
JCR Posición: 29/60
JCR Categoría:  PERIPHERAL VASCULAR DISEASE

Fernández Ruiz M, López Medrano F, Allende LM, Andrés A, Paz Artal E, Aguado JM. Assessing the risk of de novo malignancy in kidney transplant recipients: role for monitoring of peripheral blood lymphocyte populations. Transplantation. 2014;98(5):e36-7 [PubMed]
JCR Factor de Impacto: 3,828
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 4/25
JCR Categoría: TRANSPLANTATION

Fouque D, Casal MC, Lindley E, Rogers S, Pancířová J, Kernc J, et al. Dietary trends and management of hyperphosphatemia among patients with chronic kidney disease: an international survey of renal care professionals. J Ren Nutr. 2014;24(2):110-5 [PubMed]
JCR Factor de Impacto: 1,871
JCR Cuartil: Q2
JCR Decil: D5
JCR Posición: 36/78
JCR Categoría: UROLOGY & NEPHROLOGY

Gorostidi M, Santamaría R, Alcázar R, Fernández Fresnedo G, Galcerán JM, Goicoechea M, et al. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease. Nefrologia. 2014;34(3):302-16 [PubMed]
JCR Factor de Impacto: 1,223
JCR Cuartil: Q3
JCR Decil: D8
JCR Posición: 57/78
JCR Categoría: UROLOGY & NEPHROLOGY

Gutiérrez E, Moreno JA, Praga M. Persistent microhaematuria with negative or low proteinuria. Nefrologia. 2014;34(1):110-4 [PubMed]
JCR Factor de Impacto: 1,223
JCR Cuartil: Q3
JCR Decil: D8
JCR Posición: 57/78
JCR Categoría: UROLOGY & NEPHROLOGY

Lebranchu Y, Baan C, Biancone L, Legendre C, Maria Morales J, Naesens M, et al. Pretransplant identification of acute rejection risk following kidney transplantation. Transplant Int. 2014;27(2):129-38 [PubMed]
JCR Factor de Impacto: 2,599
JCR Cuartil: Q2
JCR Decil: D3
JCR Posición: 50/198
JCR Categoría: SURGERY

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Boehm M, et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press. 2014;23(1):3-16 [PubMed]
JCR Factor de Impacto: 1,808
JCR Cuartil: Q3
JCR Decil: D8
JCR Posición: 44/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Medina Polo J, Pamplona Casamayor M, Miranda Utrera N, González Monte E, Passas Martínez JB, Andrés Belmonte A. Dual kidney transplantation involving organs from expanded criteria donors: a review of our series and an update on current indications. Transplant Proc. 2014;46(10):3412-5 [PubMed]
JCR Factor de Impacto: – –
JCR Cuartil: – –
JCR Decil: – –
JCR Posición: – –
JCR Categoría: – –

Menne J, Ritz E, Ruilope LM, Chatzikyrkou C, Viberti G, Haller H. The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation. J Am Heart Assoc. 2014;3(2):e000810 [PubMed]
JCR Factor de Impacto: 4,306
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 24/123
JCR Categoría: CARDIAC & CARDIOVASCULAR SYSTEMS

Morales Ruiz E, Gutiérrez Martínez E, Cordero C, González Monte E, Hernández Martínez E, Praga Terente M, et al. Can organ donor be a patient with Pompe disease? Nefrologia. 2014;34(3):415-6 [PubMed]
JCR Factor de Impacto: 1,223
JCR Cuartil: Q3
JCR Decil: D8
JCR Posición: 57/78
JCR Categoría: UROLOGY & NEPHROLOGY

Panel de Expertos del Grupo de Estudio de Sida (GESIDA), la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), la Sociedad Española de Nefrología (SEN), la Sociedad Española de Bioquímica Clínica y Patología Molecular (SEQC), Gorriz JL, Gutiérrez F, et al. Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por el virus de la inmunodeficiencia humana. Enferm Infecc Microbiol Clin. 2014;32(9):583-97 [PubMed]
JCR Factor de Impacto: 2,172
JCR Cuartil: Q3
JCR Decil: D7
JCR Posición: 53/78
JCR Categoría: INFECTIOUS DISEASES

Pereira L, Ruiz Hurtado G, Rueda A, Mercadier J J, Benitah J P, Gómez AM. Calcium signaling in diabetic cardiomyocytes. Cell Calcium. 2014;56(5):372-80 [PubMed]
JCR Factor de Impacto: 3,513
JCR Cuartil: Q2
JCR Decil: D5
JCR Posición: 83/184
JCR Categoría: CELL BIOLOGY

Praga M. suPAR and focal segmental glomerulosclerosis. Nefrologia. 2014;34(2):145-8 [PubMed]
JCR Factor de Impacto: 1,223
JCR Cuartil: Q3
JCR Decil: D8
JCR Posición: 57/78
JCR Categoría: UROLOGY & NEPHROLOGY

Raff U, Ott C, Ruilope LM, Menne J, Haller H, Schmieder RE. Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes. J Hypertens. 2014;32(11):2267-76 [PubMed]
JCR Factor de Impacto: 4,720
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 10/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Ruilope LM. Arterial function and cardiorenal damage. J Clin Hypertens (Greenwich). 2014;16(6):398 [PubMed]
JCR Factor de Impacto: 2,851
JCR Cuartil: Q2
JCR Decil: D5
JCR Posición: 26/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Ruilope LM. Blood pressure and uric acid in diabetes mellitus. J Clin Hypertens. 2014;16(4):269 [PubMed]
JCR Factor de Impacto: 2,851
JCR Cuartil: Q2
JCR Decil: D5
JCR Posición: 26/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Ruilope LM. Renin-angiotensin system blockade: time for a reappraisal? Eur Heart J. 2014;35(26):1703-5 [PubMed]
JCR Factor de Impacto: 15,203
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 2/123
JCR Categoría: CARDIAC & CARDIOVASCULAR SYSTEMS

Ruilope LM. Understanding visit-to-visit blood pressure variability. J Clin Hypertens (Greenwich). 2014;16(1):8-9 [PubMed]
JCR Factor de Impacto: 2,851
JCR Cuartil: Q2
JCR Decil: D1
JCR Posición: 26/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, et al. Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy. Am J Nephrol. 2014;40(6):572-81 [PubMed]
JCR Factor de Impacto: 2,669
JCR Cuartil: Q2
JCR Decil: D3
JCR Posición: 22/78
JCR Categoría: UROLOGY & NEPHROLOGY

Ruilope L, Hanefeld M, Lincoff AM, Viberti G, Meyer-Reigner S, Mudie N, et al. Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study. BMC Nephrol. 2014;15:180 [PubMed]
JCR Factor de Impacto: 1,690
JCR Cuartil: Q3
JCR Decil: D6
JCR Posición: 43/78
JCR Categoría: UROLOGY & NEPHROLOGY

Ruilope L, Schaefer A. The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension (vol 30, pg 1086, 2013). Adv Ther. 2014;31(2):243 [erratum]
JCR Factor de Impacto: 2,272
JCR Cuartil: Q3
JCR Decil: D6
JCR Posición: 132/255
JCR Categoría: PHARMACOLOGY & PHARMACY

Ruiz García R, Serrano M, Martínez Flores JA, Mora S, Morillas L, Martín Mola MA, et al. Isolated IgA anti- beta2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome. J Immunol Res. 2014;2014:704395-704395 [PubMed]
JCR Factor de Impacto: – –
JCR Cuartil: Q4
JCR Decil: D10
JCR Posición: 148/148
JCR Categoría: IMMUNOLOGY

Ruiz Hurtado G, Condezo Hoyos L, Pulido Olmo H, Aranguez I, Gónzalez MC, Arribas S, et al. Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression. J Hypertens. 2014;32(10):2082-91 [PubMed]
JCR Factor de Impacto: 4,720
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 10/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Ruiz Hurtado G, Ruilope LM. Does cardiovascular protection translate into renal protection? Nat Rev Cardiol. 2014;11(12):742-6 [PubMed]
JCR Factor de Impacto: 9,183
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 5/123
JCR Categoría: CARDIAC & CARDIOVASCULAR SYSTEMS

Ruiz Hurtado G, Ruilope LM. Hypertension and obesity: correlates with renin-angiotensin-aldosterone system and uric acid. J Clin Hypertens (Greenwich). 2014;16(8):559-60 [PubMed]
JCR Factor de Impacto: 2,851
JCR Cuartil: Q2
JCR Decil: D5
JCR Posición: 26/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Sarafidis PA, Ruilope LM. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation? Kidney Int. 2014;85(3):536-46 [PubMed]
JCR Factor de Impacto: 8,563
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 4/78
JCR Categoría: UROLOGY & NEPHROLOGY

Sarafidis PA, Ruilope LM. The authors reply. Kidney Int. 2014;86(4):855 [Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?] [PubMed]
JCR Factor de Impacto: 8,563
JCR Cuartil: Q1
JCR Decil: D1
JCR Posición: 4/78
JCR Categoría: UROLOGY & NEPHROLOGY

Sánchez Chaparro MA, Calvo Bonacho E, González Quintela A, Cabrera M, Quevedo Aguado L, Fernández Labandera C, et al. Estimating the glomerular filtration rate in the Spanish working population: chronic kidney disease prevalence and its association with risk factors. J Hypertens. 2014;32(10):1970-8 [PubMed]
JCR Factor de Impacto: 4,720
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 10/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Schmieder RE, Volpe M, Waeber B, Ruilope LM. A guide for easy- and difficult-to-treat hypertension. Int J Cardiol. 2014;172(1):17-22 [PubMed]
JCR Factor de Impacto: 4,036
JCR Cuartil: Q1
JCR Decil: D3
JCR Posición: 28/123
JCR Categoría: CARDIAC & CARDIOVASCULAR SYSTEMS

Segura J, Banegas JR, Ruilope LM. Usefulness of ambulatory blood pressure monitoring (ABPM) in daily clinical practice: Data from the Spanish ABPM registry. Clin Exp Pharmacol Physiol. 2014;41(1):30-6 [PubMed]
JCR Factor de Impacto: 2,372
JCR Cuartil: Q2
JCR Decil: D5
JCR Posición: 126/255
JCR Categoría: PHARMACOLOGY & PHARMACY

Serrano M, Martínez Flores JA, Castro MJ, García F, Lora D, Pérez D, et al. Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein I antibodies in patients with endstage renal disease. J Immunol Res. 2014;2014:641962 [PubMed]
JCR Factor de Impacto: – –
JCR Cuartil: Q4
JCR Decil: D10
JCR Posición: 148/148
JCR Categoría: IMMUNOLOGY

Sevillano AM, Gutierrez E, Morales E, Hernandez E, Molina M, Gonzalez E, et al. Multiple kidney cysts in thin basement membrane disease with proteinuria and kidney function impairment. Clin Kidney J. 2014;7(3):251-6 [PubMed]
JCR Factor de Impacto: – –
JCR Cuartil: – –
JCR Decil: – –
JCR Posición: – –
JCR Categoría: – –

Tamargo J, Segura J, Ruilope LM. Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics. Expert Opin Pharmacother. 2014;15(4):527-47 [PubMed]
JCR Factor de Impacto: 3,534
JCR Cuartil: Q1
JCR Decil: D3
JCR Posición: 60/255
JCR Categoría: PHARMACOLOGY & PHARMACY

Tamargo J, Segura J, Ruilope LM. Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents. Expert Opin Pharmacother. 2014;15(5):605-21 [PubMed]}
JCR Factor de Impacto: 3,534
JCR Cuartil: Q1
JCR Decil: D3
JCR Posición: 60/255
JCR Categoría: PHARMACOLOGY & PHARMACY

Tamargo J, Solini A, Ruilope LM. Comparison of agents that affect aldosterone action. Semin Nephrol. 2014;34(3):285-306 [PubMed]
JCR Factor de Impacto: 3,483
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 15/78
JCR Categoría: UROLOGY & NEPHROLOGY

Torregrosa JV, Morales E, Díaz JM, Crespo J, Bravo J, Gómez G, et al. Cinacalcet in the management of normocalcaemic secondary hyperparathyroidism after kidney transplantation: one-year follow-up multicentre study. Nefrologia. 2014;34(1):62-8 [PubMed]
JCR Factor de Impacto: 1,223
JCR Cuartil: Q3
JCR Decil: D8
JCR Posición: 57/78
JCR Categoría: UROLOGY & NEPHROLOGY

Torregrosa JV, Morales E, Diaz JM, Crespo J, Bravo J, Gómez G, et al. Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study. Nephrology. 2014;19(2):84-93 [PubMed]
JCR Factor de Impacto: 2,083
JCR Cuartil: Q2
JCR Decil: D4
JCR Posición: 31/78
JCR Categoría: UROLOGY & NEPHROLOGY

Vinyoles E, Sierra ADL, Roso A, Cruz JJ de L, Gorostidi M, Segura J, et al. Reply: contribution of the ABP-International study to the definition of night-time tachycardia. J Hypertens. 2014;32(10):2101 [PubMed]
JCR Factor de Impacto: 4,720
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 10/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, et al. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens. 2014;32(9):1888-97 [PubMed]
JCR Factor de Impacto: 4,720
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 10/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, et al. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens. 2014;32(9):1741-50 [PubMed]
JCR Factor de Impacto: 4,720
JCR Cuartil: Q1
JCR Decil: D2
JCR Posición: 10/60
JCR Categoría: PERIPHERAL VASCULAR DISEASE

.

2015

Artículos

Auñón P, Morales E. Reply to the comment “Infection with hepatitis C virus, interferon α and lupus: An odd association”. Nefrologia. 2015;35(5):507-8 [PubMed]

 

Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, et al. Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial. JAMA. 2015;314(9):884-94 [PubMed]

 

Baldán Martín M, De la Cuesta F, Álvarez Llamas G, González Calero L, Ruiz Hurtado G, Moreno Luna R, et al. Prediction of development and maintenance of high albuminuria during chronic renin-angiotensin suppression by plasma proteomics. Int J Cardiol. 2015;196:170-7 [PubMed]

 

Banegas JR, Navarro Vidal B, Ruilope LM, De la Cruz JJ, López García E, Rodríguez Artalejo F, et al. Trends in hypertension control among the older population of Spain from 2000 to 2001 to 2008 to 2010: role of frequency and intensity of drug treatment. Circ Cardiovasc Qual Outcomes. 2015;8(1):67-76 [PubMed]

 

Bavishi C, Messerli FH, Kadosh B, Ruilope LM, Kario K. Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials. Eur Heart J. 2015;36(30):1967-73 [PubMed]

 

Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, et al. First Report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015;65(4):766-74 [PubMed]

 

Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, et al. An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document. Nefrologia. 2015;35(5):421-47 [PubMed]

 

Caro J, Gutiérrez Solís E, Rojas Rivera J, Agraz I, Ramos N, Rabasco C, et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. Nephrol Dial Transplant. 2015;30(3):467-74 [PubMed]

 

Catalina Romero C, Ruilope LM, Sánchez Chaparro MA, Valdivielso P, Cabrera Sierra M, Fernández Labandera C, et al. Factors influencing return-to-work after cerebrovascular disease: the importance of previous cardiovascular risk. Eur J Prev Cardiol. 2015;22(9):1220-7 [PubMed]

 

Coppo R, Lofaro DD, Camilla RR, Bellur S, Cattran D, Cook HT, et al. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. Pediatr Nephrol. 25 de agosto de 2016 [PubMed]

 

De Barbieri I, Baumann J, Casal MC, Gurevich A, Pancirova J, Poulia K-A, et al. An overview of nurses’ management of secondary hyperparathyroidism: How is Europe doing? J Ren Care. 2015;41(3):202-10 [PubMed]

 

De la Sierra A, Gorostidi M, Banegas JR, Segura J, Vinyoles E, De la Cruz JJ, et al. Ambulatory blood pressures in hypertensive patients treated with one antihypertensive agent: differences among drug classes and among drugs belonging to the same class. J Clin Hypertens (Greenwich). 2015;17(11):857-65 [PubMed]

 

Erdmann E, Califf R, Gerstein HC, Malmberg K, Ruilope L, Schwartz GG, et al. Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes. Am Heart J. 2015;170(1):117-22 [PubMed]

 

Fernández Ruiz M, Arias M, Campistol JM, Navarro D, Gómez Huertas E, Gómez Márquez G, et al. Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice. Transpl Int. 2015;28(9):1042-54 [PubMed]

 

García Montemayor V, Agüera ML, Rabasco C, Navarro MD, Rodríguez Benot A, Aljama P. Development of donor-specific anti-HLA antibodies after restarting hemodialysis due to graft failure. Transplant Proc. 2015;47(9):2626-30 [PubMed]

 

García Prieto CF, Pulido Olmo H, Ruiz Hurtado G, Gil Ortega M, Arangüez I, Rubio MA, et al. Mild caloric restriction reduces blood pressure and activates endothelial AMPK-PI3K-Akt-eNOS pathway in obese Zucker rats. Vascul Pharmacol. 2015;65-66:3-12 [PubMed]

 

Gargallo V, Angulo L, Hernández E, Peralto JL, Zarco C. Massive subcutaneous masses on the back related to β2-microglobulin amyloidosis. JAMA Dermatol. 2015;151(5):564-5 [PubMed]

 

González Monte E, Mora MT, Polanco N, Morales E, Gutiérrez E, Molina M, et al. Impact of left ventricular dysfunction on renal transplant survival: study of paired kidneys from the same donor. Transplant Proc. 2015;47(1):70-2 [PubMed]

 

Gorostidi M, Sarafidis P, Sierra ADL, Banegas JR, De La Cruz JJ, Vinyoles E, et al. Blood pressure variability increases with advancing chronic kidney disease stage. A cross-sectional analysis of 14,382 hypertensive patients from Spain. J Hypertens. 2015;33 Suppl 1:e40 [PubMed]

 

Guijarro C, Ruilope LM. Colesterol ligado a lipoproteínas de baja densidad (LDL) y reducción del riesgo vascular. Proproteína convertasa subtilisina / kexina tipo 9 (PCSK9): una nueva diana terapéutica. Med Clin (Barc). 2015;145(2):67-9 [PubMed]

 

Hoshide S, Kario K, De la Sierra A, Bilo G, Schillaci G, Banegas JR, et al. Ethnic differences in the degree of morning blood pressure surge and in its determinants between japanese and european hypertensive subjects: data from the ARTEMIS tudy. Hypertension. 2015;66(4):750-6 [PubMed]

 

Mahfoud F, Böhm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, et al. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. Eur Heart J. 2015;36(33):2219-27 [PubMed]

 

Mahfoud F, Linz D, Mancia G, Narkiewicz K, Ruilope LM, Schlaich MP, et al. Renal artery denervation for treatment of hypertensive patients with or without obstructive sleep apnea and resistant hypertension: results from the global symplicity registry. J Hypertens. 2015;33 Suppl 1:e108 [PubMed]

 

Mahfoud F, Ruilope LM, Böhm M, Schmieder RE. Aldosterone antagonists and renal denervation: friends or foes? Hypertension. 2015;65(2):280-2 [PubMed]

 

Mancia G, Mahfoud F, Narkiewicz K, Ruilope LM, Schlaich MP, Schmieder RE, et al. Long-term effects of renal artery denervation in real world patients with uncontrolled hypertension from the global symplicity registry. J Hypertens. 2015;33 Suppl 1:e49 [PubMed]

 

Márquez DF, Ruiz Hurtado G, Ruilope LM, Segura J. An update of the blockade of the renin angiotensin aldosterone system in clinical practice. Expert Opin Pharmacother. 2015;16(15):2283-92 [PubMed]

 

Martín Lorenzo M, Zubiri I, Maroto AS, González Calero L, Posada Ayala M, De la Cuesta F, et al. KLK1 and ZG16B proteins and arginine-proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery. Metabolomics. 2015;11(5):1056-67 [PubMed]

 

Martínez Castelao A, Gorostidi M, Górriz JL, Santamaría Olmo R, Bover J, Segura J. Reflections on two consensus documents about chronic kidney disease. Nefrologia. 2015;35(2):127-30 [PubMed]

 

Miranda Utrera N, Medina Polo J, Pamplona Casamayor M, Passas Martínez JB, Rodríguez Antolín A, De la Rosa Kehrmann F, et al. Uncontrolled non-heartbeating donors (types i-ii) with normothermic recirculation vs. heartbeating donors: Evaluation of functional results and survival. Actas Urol Esp. 2015;39(7):429-34 [PubMed]

 

Molina M, Apaza J, González Monte E, Gutiérrez Martínez E, Sevillano AM, Marín JP, et al. Results of kidney transplantation from deceased donors with acute kidney injury. Transplant Proc. 2015;47(1):42-4 [PubMed]

 

Morales E, Caro J, Gutiérrez E, Sevillano A, Auñón P, Fernández C, et al. Diverse diuretics regimens differentially enhance the antialbuminuric effect of renin-angiotensin blockers in patients with chronic kidney disease. Kidney Int. 26 de agosto de 2015 [PubMed]

 

Morales E, Gutiérrez E, Caro J, Sevillano A, Rojas Rivera J, Praga M. Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria. Nefrologia. 2015;35(6):554-61 [PubMed]

 

Morales E, Gutiérrez E, Hernández A, Rojas Rivera J, Gonzalez E, Hernández E, et al. Preemptive kidney transplantation in elderly recipients with kidneys discarded of very old donors: A good alternative. Nefrologia. 2015;35(3):246-55 [PubMed]

 

Morales E, Rabasco C, Gutiérrez E, Praga M. A case of thrombotic microangiopathy after heart transplantation successfully treated with eculizumab. Transpl Int. 2015;28(7):878-80 [PubMed]

 

Morales E, Rabasco C, Panizo N, Gutiérrez E, Martínez MA, Toldos O, et al. Mesangial nephropathy and anti-syntethase syndrome: An odd association. Nefrologia. 2015;35(4):415-7 [PubMed]

 

Peña JC, Ruilope LM. LCZ696, The need for an indication in arterial hypertension. Am J Hypertens. 2015;28(12):1403-4 [PubMed]

 

Pérez-Jacoiste Asín MA, Fernández Ruiz M, González E, Manzano Peña MT. Infección diseminada por Bartonella henselae en un receptor de trasplante renal. Enferm Infecc Microbiol Clin. 2015;33(4):292-3 [PubMed]

 

Polanco N, González Monte E, Folgueira MD, Morales E, Gutiérrez Martínez E, Bengoa I, et al. Everolimus-based imunosuppression therapy for BK virus nephropathy. Transplant Proc. 2015;47(1):57-61 [PubMed]

 

Porrini E, Ruggenenti P, Mogensen CE, Barlovic DP, Praga M, Cruzado JM, et al. Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes. Lancet Diabetes Endocrinol. 2015;3(5):382-91 [PubMed]

 

Praga M, Sevillano A, Auñón P, González E. Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant. 2015;30(9):1472-9 [PubMed]

 

Pulido Olmo H, Gracia Prieto CF, Somoza B, Aránguez I, Álvarez Llamas G, Vivanco F, et al. Matrix metalloproteinase (MMP) 2 and MMP9 activity is increased in conditions of albuminuria escape under chronic renin-angiotensin system suppression. J Hypertens. 2015;33 Suppl 1:e115-6 [PubMed]

 

Rabasco C, Cavero T, Román E, Rojas Rivera J, Olea T, Espinosa M, et al. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis. Kidney Int. 2015;88(5):1153-60 [PubMed]

 

Rodríguez Rodríguez P, De Pablo ALL, Condezo Hoyos L, Martín Cabrejas MA, Aguilera Y, Ruiz Hurtado G, et al. Fetal undernutrition is associated with perinatal sex-dependent alterations in oxidative status. J Nutr Biochem. 2015;26(12):1650-9 [PubMed]

 

Rojas Rivera J, Fernández Juárez G, Ortiz A, Hofstra J, Gesualdo L, Tesar V, et al. A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with Tacrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study. Clin Kidney J. 2015;8(5):503-10 [PubMed]

 

Rojas Rivera J, Fernández Juárez G, Praga M. Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease? Clin Kidney J. 2015;8(5):477-81 [PubMed]

 

Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, et al. Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy. Am J Nephrol. 2015;40(6):572-81 [PubMed]

 

Ruilope L, Schaefer A. Erratum to: the fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension. Adv Ther. 2015;32(2):184-5 [PubMed]

 

Ruiz Hurtado G, Gorostidi M, Waeber B, Ruilope LM. Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements? Curr Opin Nephrol Hypertens. 2015;24(6):488-91 [PubMed]

 

Ruiz Hurtado G, Gorostidi M, Waeber B, Ruilope LM. Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements? Curr Opin Nephrol Hypertens. 2015;24(6):488-91 [PubMed]

 

Ruiz Hurtado G, Ruilope LM. Salutary cardiovascular effects of antidiabetic drugs: myth or fact? J Hypertens. 2015;33(11):2198-9 [PubMed]

 

San Juan R, Navarro D, García Reyne A, Montejo M, Muñoz P, Carratala J, et al. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients. Transpl Infect Dis. 2015;17(5):637-46 [PubMed]

 

San Juan R, Navarro D, García Reyne A, Montejo M, Muñoz P, Carratala J, et al. Effect of delaying prophylaxis against CMV in D+/R-solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease. J Infect. 2015;71(5):561-70 [PubMed]

 

Yuste C, Rubio Navarro A, Barraca D, Aragoncillo I, Vega A, Abad S, et al. Haematuria increases progression of advanced proteinuric kidney disease. PLoS One. 2015;10(5):e0128575 [PubMed]

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión /  Cambiar )

Google photo

Estás comentando usando tu cuenta de Google. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )

Conectando a %s